Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–8 of 8 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06017258
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, +9 more
- Locations
-
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
NCT06177067
- Conditions
- Acute Leukemia of Ambiguous Lineage, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Rady Children's Hospital San Diego, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- Children's Mercy Hospital of Kansas City Kansas City, Missouri, United States
Recruiting
Imetelstat Combinations in Relapsed AML
NCT07320235
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
Recruiting
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
NCT04797767
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +26 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT06561152
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Stanford University Palo Alto, California, United States
NCT02996474
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Completed
Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT01961765
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, Not Recruiting
FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies
NCT04891757
- Conditions
- Advanced Hematologic Malignancy, Bone Marrow Diseases, Chronic Disease, +19 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Vanderbilt University Medical Center Nashville, Tennessee, United States